{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:13Z","timestamp":1783606933722,"version":"3.55.0"},"reference-count":34,"publisher":"Bioscientifica","issue":"12","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>Follicular thyroid carcinoma (FTC) and oncocytic thyroid carcinoma (OTC) are distinct entities with differing biological behaviors, yet optimal surgical and radioactive iodine (RAI) therapy management remains debated. Demographic, clinicopathological, and treatment characteristics were gathered from the Surveillance, Epidemiology, and End Results (SEER) database and compared between FTC and OTC according to tumor size. The Kaplan\u2013Meier method and log-rank test were used to analyze cancer-specific survival (CSS). The effect of potential predictors associated with survival was estimated using the Cox regression model. 13,653 patients were included in our study. OTC patients were older and presented higher rates of extrathyroidal extension (ETE) and lymph node metastases (LNM), while FTC had higher distant metastasis (DM) rates. Increasing tumor size was correlated with worse features in both subtypes. Total thyroidectomy (TT) had no CSS benefit over less than TT (LTT) for FTC \u22642 cm or any OTC size group. TT was paradoxically associated with worse CSS for FTC &amp;gt;2 cm. RAI therapy did not improve CSS for patients with ETE (FTC or OTC) or DM (OTC). Multivariable analysis confirmed that TT was independently associated with worse CSS in FTC but not in OTC, while RAI therapy was beneficial in FTC but not in OTC. FTC and OTC exhibited distinct clinical behaviors. In conclusion, TT did not improve CSS for small FTC (\u22642 cm) or any OTC, and appeared to be associated with worse outcomes in larger FTC. RAI therapy provided limited benefit in OTC, especially with DM. Treatment should be individualized, avoiding routine aggressive surgery or RAI.<\/jats:p>","DOI":"10.1530\/erc-25-0373","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:09:18Z","timestamp":1763554158000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Clinical differences and surgery in follicular vs oncocytic thyroid carcinomas"],"prefix":"10.1530","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7544-404X","authenticated-orcid":true,"given":"Jingzhe","family":"Xiang","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixue","family":"Hou","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2026070909450571600_bib1","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973\u20132002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"2026070909450571600_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070909450571600_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026070909450571600_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"2026070909450571600_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12022-018-9548-1","article-title":"Clinically relevant prognostic parameters in differentiated thyroid carcinoma","volume":"29","author":"Janovitz","year":"2018","journal-title":"Endocr Pathol"},{"key":"2026070909450571600_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/thy.2019.0088","article-title":"Short review: genomic alterations in H\u00fcrthle cell carcinoma","volume":"29","author":"Ganly","year":"2019","journal-title":"Thyroid"},{"key":"2026070909450571600_bib7","volume-title":"Pathology and Genetics of Tumours of Endocrine Organs","author":"DeLellis","year":"2004","edition":"3rd edn"},{"key":"2026070909450571600_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.795184","article-title":"Oncocytic papillary thyroid carcinoma and oncocytic poorly differentiated thyroid carcinoma: clinical features, uptake, and response to radioactive iodine therapy, and outcome","volume":"12","author":"Lukovic","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070909450571600_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","journal-title":"Cancer Cell"},{"key":"2026070909450571600_bib10","volume-title":"WHO Classification of Tumours of Endocrine Organs","author":"Lloyd","year":"2017","edition":"4th edn"},{"key":"2026070909450571600_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070909450571600_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0146","article-title":"Management of follicular thyroid carcinoma","volume":"13","author":"Yamazaki","year":"2024","journal-title":"Eur Thyroid J"},{"key":"2026070909450571600_bib13","article-title":"Advances in the diagnosis and treatment of follicular thyroid carcinoma: a comprehensive review","volume":"16","author":"Gopalan","year":"2024","journal-title":"Cureus"},{"key":"2026070909450571600_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamaoto.2023.4323","article-title":"Molecular alterations and comprehensive clinical management of oncocytic thyroid carcinoma: a review and multidisciplinary 2023 update","volume":"150","author":"Bischoff","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026070909450571600_bib15","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1245\/s10434-013-2965-y","article-title":"Does H\u00fcrthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?","volume":"20","author":"Sugino","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2026070909450571600_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.696386","article-title":"Genetics, diagnosis, and management of H\u00fcrthle cell thyroid neoplasms","volume":"12","author":"McFadden","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070909450571600_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070909450571600_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.30708","article-title":"Molecular testing for thyroid nodules: review and current state","volume":"124","author":"Roth","year":"2018","journal-title":"Cancer"},{"key":"2026070909450571600_bib19","volume-title":"Surveillance, Epidemiology, and End Results Program","author":"National Cancer Institute","year":"2023"},{"key":"2026070909450571600_bib20","first-page":"108","article-title":"Characteristics of malignant thyroid tumors: a retrospective study on 320 patients","volume":"59","author":"Abi\u010di\u0107","year":"2020","journal-title":"Acta Clin Croat"},{"key":"2026070909450571600_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2017.0526","article-title":"Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: implications for biopsy guidelines","volume":"28","author":"Nguyen","year":"2018","journal-title":"Thyroid"},{"key":"2026070909450571600_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3904\/kjim.2014.29.3.325","article-title":"Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data","volume":"29","author":"Kim","year":"2014","journal-title":"Korean J Intern Med"},{"key":"2026070909450571600_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00405-024-08965-7","article-title":"Comparison of prognosis between oncocytic thyroid carcinoma and follicular thyroid carcinoma: a population-based propensity score matching analysis","volume":"282","author":"Peng","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2026070909450571600_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/thy.2021.0424","article-title":"Follicular and Hurthle cell carcinoma: comparison of clinicopathological features and clinical outcomes","volume":"32","author":"Matsuura","year":"2022","journal-title":"Thyroid"},{"key":"2026070909450571600_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00259-020-04952-2","article-title":"Clinical impact of follicular oncocytic (H\u00fcrthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma","volume":"48","author":"Wenter","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909450571600_bib26","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1245\/s10434-020-09397-3","article-title":"Outcomes for minimally invasive follicular thyroid carcinoma in relation to the change in age stratification in the AJCC 8th edition","volume":"28","author":"Yamazaki","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026070909450571600_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1507\/endocrj.EJ22-0077","article-title":"Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion","volume":"69","author":"Ito","year":"2022","journal-title":"Endocr J"},{"key":"2026070909450571600_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0039-6060(98)70036-4","article-title":"Follicular and H\u00fcrthle cell carcinoma: predicting outcome and directing therapy","volume":"124","author":"Sanders","year":"1998","journal-title":"Surgery"},{"key":"2026070909450571600_bib29","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.surg.2013.04.033","article-title":"Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients","volume":"154","author":"Kuo","year":"2013","journal-title":"Surgery"},{"key":"2026070909450571600_bib30","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics"},{"key":"2026070909450571600_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of h\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly","year":"2018","journal-title":"Cancer Cell"},{"key":"2026070909450571600_bib32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/thy.2016.0246","article-title":"Radioactive iodine treatment is associated with improved survival for patients with H\u00fcrthle cell carcinoma","volume":"26","author":"Jillard","year":"2016","journal-title":"Thyroid"},{"key":"2026070909450571600_bib33","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7458","article-title":"Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (H\u00fcrthle cell carcinoma)","volume":"7","author":"Yang","year":"2019","journal-title":"PeerJ"},{"key":"2026070909450571600_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12885-016-2179-3","article-title":"Treatment and outcome of 32 patients with distant metastases of H\u00fcrthle cell thyroid carcinoma: a single-institution experience","volume":"16","author":"Besic","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/12\/ERC-25-0373.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/12\/ERC-25-0373.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0373\/505768\/erc-25-0373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0373\/505768\/erc-25-0373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:45:21Z","timestamp":1783604721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/12\/e250373\/75545\/Clinical-differences-and-surgery-in-follicular-vs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0373","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"e250373"}}